[Webinar] FibroGen Update on Pamrevlumab & Currently Enrolling Non-Ambulatory Study
Event Details
![[Webinar] FibroGen Update on Pamrevlumab & Currently Enrolling Non-Ambulatory Study](http://api.ning.com/files/nZXfLD2-U3IF9HY-*5OaIldR7VDECPGBQ9i9nL0vHhBtmfFZ8L-s0dDA3uMxa1IoQCzR*okcT19ggzmt1tfFf0kDmp1jfN6n/webinaroct25.png?profile=RESIZE_180x180&size=173&crop=1%3A1)
Time: October 25, 2017 from 1pm to 2pm
Location: Online Webinar - Eastern Time Zone
Website or Map: http://www.parentprojectmd.or…
Event Type: webinar
Organized By: PPMD
Latest Activity: Oct 18, 2017
Export to Outlook or iCal (.ics)
Event Description
Please join Parent Project Muscular Dystrophy and FibroGen as we host a webinar Wednesday, October 25 at 1:00 PM EDT to hear a community update on FibroGen’s development of Pamrevlumab and currently enrolling FGCL-3019-079 non-ambulatory study in Duchenne muscular dystrophy.
Host:
- Kathi Kinnett, MSN, CNP
Senior Vice President, Clinical Care
Parent Project Muscular Dystrophy
Speaker:
- Elias Kouchakji, MD
Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
FibroGen
To Participate:
View call-in information & pre-register to receive a reminder email for this webinar.
Submit Questions:
Please submit questions in advance to info@parentprojectmd.org (subject line: FibroGen Webinar) by Monday, October 23rd at 12:00 PM ET.
Comment Wall
Comment
© 2019 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
RSVP for [Webinar] FibroGen Update on Pamrevlumab & Currently Enrolling Non-Ambulatory Study to add comments!
Join PPMD Community